9-22043927-A-G

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NR_003529.4(CDKN2B-AS1):n.847-2390A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.279 (AC=42,435) in the gnomAD database across 151,872 control chromosomes, including 7,702 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.41. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 7702 hom., cov: 32)

Consequence

CDKN2B-AS1
NR_003529.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.908

Publications

118 publications found
Variant links:
Genes affected
CDKN2B-AS1 (HGNC:34341): (CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1) This gene is located within the CDKN2B-CDKN2A gene cluster at chromosome 9p21. The gene product is a functional RNA molecule that interacts with polycomb repressive complex-1 (PRC1) and -2 (PRC2), leading to epigenetic silencing of other genes in this cluster. This region is a significant genetic susceptibility locus for cardiovascular disease, and has also been linked to a number of other pathologies, including several cancers, intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma. Multiple alternatively processed transcript variants have been detected, some of which may take the form of circular RNA molecules (PMID:21151960). [provided by RefSeq, May 2014]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NR_003529.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.4099 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NR_003529.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CDKN2B-AS1 NR_003529.4
MANE Select
HGVSc / HGVSpn.847-2390A>G
Exon rankIntron 3 of 18
intron
Prot:
CDKN2B-AS1 NR_047532.2
HGVSc / HGVSpn.534-2390A>G
Exon rankIntron 2 of 13
intron
Prot:
CDKN2B-AS1 NR_047533.2
HGVSc / HGVSpn.372-2824A>G
Exon rankIntron 1 of 3
intron
Prot:

Ensembl Transcripts

CDKN2B-AS1 ENST00000428597.7
TSL:1MANE Select
HGVSc / HGVSpn.847-2390A>G
Exon rankIntron 3 of 18
intron
Prot:
CDKN2B-AS1 ENST00000455933.8
TSL:1
HGVSc / HGVSpn.341-2824A>G
Exon rankIntron 1 of 4
intron
Prot:
CDKN2B-AS1 ENST00000577551.5
TSL:1
HGVSc / HGVSpn.261-2824A>G
Exon rankIntron 1 of 6
intron
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.280
AC:42429
Hom:7696
AN:151754
Cov:32
GnomAD4 genome
AF: 0.279
AC:42435
Hom:7702
AN:151872
Cov:32
TOPMed (Bravo)
AF: 0.256
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.369
AC:229370
Hom:46174
AN:622178
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.255
AC:597
Hom:83
AN:2342
ChinaMAP Phase 1
AF: 0.120
Denmark Genome
AF: 0.513
AC:154
AN:300
GenomeAsia100K
AF: 0.204
AC:711
AN:3474
Korea4K (4,157 Koreans)
AF: 0.134
AC:971
AN:7226
Qatari Genome
AF: 0.224
AC:39
AN:174
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.158
AC:19248
Hom:1534
AN:122042
Turkish Variome
AF: 0.290
AC:448
Hom:66
AN:1546
UK10K
AF: 0.421
AC:3181
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.112
AC:1001
Hom:60
AN:8960
Showing 14 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign0.41
BayesDel_noAF
Benign-0.95
CADD
Benign0.32
DANN
Benign0.55
GPN-Star LLR
N/A2.2
GPN-Star score
N/A-1.5
PhyloP100
Benign-0.91
Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.